| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3335020 | Transfusion and Apheresis Science | 2013 | 4 Pages |
Abstract
It has become clear that diffuse large B-cell lymphoma is not a uniform antibody. Several recognizable variants have clinically distinct features and, frequently, require specific treatment approaches. Recognition of these variants and utilization of the appropriate treatments will improve the outcome for the patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
James O. Armitage,